Epitopea
Medtech startup is developing off-the-shelf cancer immunotherapies designed to treat a broad patient population
Cambridge, UKwww.epitopea.com ↗
Total raised
€12M
€12,232,648
Funding rounds
1
Investors
6
distinct backers
Active since
2022-04
latest 2022-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood16
base rate 44% for Seed
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-04-25 | Seed | €12M | Advent Life Sciences,Cambridge Innovation Capital,CTI Life Sciences,Fonds de solidarité FTQ,Harrington Discovery Institute,Novateur Ventures | View deal → |